Prime Medicine, Inc. Common Stock (PRME) News
Latest headlines that mention PRME, newest first · each headline opens the original publisher
- Last price
- $4.35
- Day change
- +20.50%
- Next earnings
- 2026-11-06
PRME headlines
latest coveragePrime Medicine won a legal battle with Beam Therapeutics on Wednesday. Prime shares jumped while Beam stock skidded. The post Gene Editors, Including Powerhouse Beam Therapeutics, Diverge On Legal Battle appeared first on Investor's Business Daily .
Two biotech innovators, two very different risk profiles: one with commercial products and another betting on next-gen gene editing breakthroughs.
PRME news alerts
Get an alert by email or push when a new headline mentions PRME.
More news
News headlines aggregated from third-party publishers via public RSS feeds and tagged with the tickers they mention. Frenzy Capital does not publish or endorse the content; clicking a headline opens the original publisher in a new tab.